| Ronald F Tutrone Jr, MD | |
|
6535 N Charles St, Suite 625, Baltimore, MD 21204-5826 | |
| (410) 825-5454 | |
| (410) 825-5811 |
| Full Name | Ronald F Tutrone Jr |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 37 Years |
| Location | 6535 N Charles St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265495204 | NPI | - | NPPES |
| 453900100 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | D44467 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Greater Baltimore Medical Center | Baltimore, MD | Hospital |
| York Hospital | York, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chesapeake Urology Associates Llc | 4789673393 | 134 |
News Archive
GE Healthcare, a unit of General Electric Company announced today that it has completed the tender offer by GE's wholly owned subsidiary, Crane Merger Sub, Inc., for all outstanding shares of common and preferred stock of Clarient Inc., a leading player in the fast-growing molecular diagnostics sector. Clarient provides pathologists and oncologists with access to key diagnostic tests that shed light on the complex nature of various cancers.
NiKem Research is pleased to announce that it has received on March 29th 2010, from the Italian Ministry of Health (Decree N. 69/2010-B), the authorization to perform acute and sub-chronic toxicology studies (upto 28 days) in all rodent species for preliminary safety evaluation of novel chemical entities (NCEs). Toxicokinetic (TK) studies are also allowed to correlate plasma and/or organ exposure of NCEs (and metabolites) to tolerated doses in toxicology studies.
Recovering addicts often grapple with the ghosts of their addiction—memories that tempt them to relapse even after rehabilitation and months, or even years, of drug-free living.
A new genetic approach to treating sickle cell disease is showing promising results in mice, report researchers from Children's Hospital Boston. By inactivating a gene they previously discovered to be important in the laboratory, they were able to boost production of a healthy fetal form of hemoglobin in the mice, potentially compensating for the defective adult hemoglobin that causes red blood cells to "sickle" and obstruct blood flow.
In a literature review article published in the Journal of Community Hospital Internal Medicine Perspectives, authors from the US performed a thorough investigation of previous studies and case reports of SARS-CoV-2 reinfection. This review discusses the role of natural immunity, vaccines, and SARS-CoV-2 variants in reinfection.
› Verified 7 days ago
| Entity Name | Chesapeake Urology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609823004 PECOS PAC ID: 4789673393 Enrollment ID: O20040510000449 |
News Archive
GE Healthcare, a unit of General Electric Company announced today that it has completed the tender offer by GE's wholly owned subsidiary, Crane Merger Sub, Inc., for all outstanding shares of common and preferred stock of Clarient Inc., a leading player in the fast-growing molecular diagnostics sector. Clarient provides pathologists and oncologists with access to key diagnostic tests that shed light on the complex nature of various cancers.
NiKem Research is pleased to announce that it has received on March 29th 2010, from the Italian Ministry of Health (Decree N. 69/2010-B), the authorization to perform acute and sub-chronic toxicology studies (upto 28 days) in all rodent species for preliminary safety evaluation of novel chemical entities (NCEs). Toxicokinetic (TK) studies are also allowed to correlate plasma and/or organ exposure of NCEs (and metabolites) to tolerated doses in toxicology studies.
Recovering addicts often grapple with the ghosts of their addiction—memories that tempt them to relapse even after rehabilitation and months, or even years, of drug-free living.
A new genetic approach to treating sickle cell disease is showing promising results in mice, report researchers from Children's Hospital Boston. By inactivating a gene they previously discovered to be important in the laboratory, they were able to boost production of a healthy fetal form of hemoglobin in the mice, potentially compensating for the defective adult hemoglobin that causes red blood cells to "sickle" and obstruct blood flow.
In a literature review article published in the Journal of Community Hospital Internal Medicine Perspectives, authors from the US performed a thorough investigation of previous studies and case reports of SARS-CoV-2 reinfection. This review discusses the role of natural immunity, vaccines, and SARS-CoV-2 variants in reinfection.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald F Tutrone Jr, MD 25 Crossroads Dr, Ste 306, Owings Mills, MD 21117-5421 Ph: (410) 825-5454 | Ronald F Tutrone Jr, MD 6535 N Charles St, Suite 625, Baltimore, MD 21204-5826 Ph: (410) 825-5454 |
News Archive
GE Healthcare, a unit of General Electric Company announced today that it has completed the tender offer by GE's wholly owned subsidiary, Crane Merger Sub, Inc., for all outstanding shares of common and preferred stock of Clarient Inc., a leading player in the fast-growing molecular diagnostics sector. Clarient provides pathologists and oncologists with access to key diagnostic tests that shed light on the complex nature of various cancers.
NiKem Research is pleased to announce that it has received on March 29th 2010, from the Italian Ministry of Health (Decree N. 69/2010-B), the authorization to perform acute and sub-chronic toxicology studies (upto 28 days) in all rodent species for preliminary safety evaluation of novel chemical entities (NCEs). Toxicokinetic (TK) studies are also allowed to correlate plasma and/or organ exposure of NCEs (and metabolites) to tolerated doses in toxicology studies.
Recovering addicts often grapple with the ghosts of their addiction—memories that tempt them to relapse even after rehabilitation and months, or even years, of drug-free living.
A new genetic approach to treating sickle cell disease is showing promising results in mice, report researchers from Children's Hospital Boston. By inactivating a gene they previously discovered to be important in the laboratory, they were able to boost production of a healthy fetal form of hemoglobin in the mice, potentially compensating for the defective adult hemoglobin that causes red blood cells to "sickle" and obstruct blood flow.
In a literature review article published in the Journal of Community Hospital Internal Medicine Perspectives, authors from the US performed a thorough investigation of previous studies and case reports of SARS-CoV-2 reinfection. This review discusses the role of natural immunity, vaccines, and SARS-CoV-2 variants in reinfection.
› Verified 7 days ago
Dr. Marcel I. Horowitz, M. D. Urology Medicare: Not Enrolled in Medicare Practice Location: 838 N Eutaw St, Baltimore, MD 21201 Phone: 410-523-2150 | |
Dr. Ryan Christopher Cleary, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 6820 Hospital Dr Ste 201, Baltimore, MD 21237 Phone: 410-581-1600 | |
Alan Louis Kaplan, M.D. Urology Medicare: Medicare Enrolled Practice Location: 3407 Wilkens Ave Ste 210, Baltimore, MD 21229 Phone: 410-581-1600 | |
Kannan Manickam, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 6820 Hospital Dr, Suite 210, Baltimore, MD 21237 Phone: 410-391-6131 Fax: 410-391-6144 | |
Robert A Thompson Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 301 Saint Paul Pl, Pob 802, Baltimore, MD 21202 Phone: 410-332-9654 Fax: 410-685-8975 | |
Dr. Ajay R Parikh, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3333 N Calvert St, Ste 605 Johnston Professional Bldg, Baltimore, MD 21218 Phone: 410-889-8899 Fax: 410-889-7924 | |
Dr. Geoffrey Neal Sklar, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 6820 Hospital Dr Ste 201, Baltimore, MD 21237 Phone: 410-760-9400 Fax: 410-787-1911 |